29

Jun

2017

Navitus Health Solutions: Pharmacy Newsletter - Issue #35

Summer 2017

Please see the attached PDF for Navitus Pharmacy Newsletter Issue #35.

28

Apr

2017

Navitus : Notice to Pharmacies - Mosquito Repellent Benefit

Texas Health and Human Services

Texas covers mosquito repellents for the prevention of the Zika virus.

13

Apr

2017

Navitus Health Solutions: Spring 2017 Newsletter

Issue #34

Please see the attached PDF for the Navitus Health Solutions: Spring 2017 Pharmacy Newsletter.

2

Jan

2017

Navitus Health Solutions: Network Bulletin - Preferred Diabetes Test Strip Program for Allegian Advantage Plan

Effective January 1st 2016

Dear Pharmacy:

This is an important message for pharmacies servicing Allegian Advantage patients.

Effective 1/1/2016, Allegian Advantage Plans implemented a preferred diabetes testing supply policy. This program will continue in 2017.

*Please see attached PDF for more information.

28

Dec

2016

Navitus Health Solutions: Network Bulletin - Concurrent Drug Utilization Review (CDUR) Edits Update

Effective January 1st 2017

Effective 1/1/2017, the Morphine Equivalent Dose (MED) edit will be upgraded from messaging only to a soft rejection with messaging for all Navitus clients. The MED edit identifies members who have active opioid prescriptions with a cumulative morphine equivalent dose of 120 mg or greater, prescribed by two or more providers, and filled at two or more pharmacies. The purpose of this edit is to alert the dispensing pharmacist of potential overutilization issues. The soft rejection will allow for a pharmacist to review the clinical appropriateness of the claim, perform any prescriber outreach (as applicable), and, when clinically appropriate, override the rejection at the point-of-sale using standard NCPDP DUR codes. In addition to the soft rejection, pharmacies will receive the following message: "High Morphine Eq Dose, Mult Prescriber/Pharmacy."
First 2345 Last